SLP – simulations plus, inc. (US:NASDAQ)
Stock Stats
News
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Here's Simulations Plus Inc (SLP)'s Vision for AI in Drug Development [Yahoo! Finance]
Simulations Plus: Better Quarter, Same Doubts [Seeking Alpha]
Simulations Plus (SLP) had its price target lowered by TD Cowen from $19.00 to $16.00. They now have a "hold" rating on the stock.
Form 4 Simulations Plus, Inc. For: Apr 15 Filed by: DiBella John Anthony II
Form 144 Simulations Plus, Inc. Filed by: DiBella John Anthony II
Form 10-Q Simulations Plus, Inc. For: Feb 28
Form 8-K Simulations Plus, Inc. For: Apr 09
Form SCHEDULE 13G/A Simulations Plus, Inc. Filed by: VANGUARD GROUP INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.